Solly, F <br/><br/>
Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.  [electronic resource] 

 -  Cancer gene therapy  Oct 2008 
 - 685-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5500 
<br/><br/><label>Standard No.: </label>10.1038/cgt.2008.36  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiostatins--metabolism<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Blotting, Western<br/>Captopril--pharmacology<br/>Cell Line, Tumor<br/>Combined Modality Therapy<br/>Genetic Therapy--methods<br/>Genetic Vectors--genetics<br/>Glioma--drug therapy<br/>Immunohistochemistry<br/>Lentivirus--genetics<br/>Male<br/>Mice<br/>Mice, Nude<br/>Neovascularization, Pathologic--drug therapy<br/>Platelet Endothelial Cell Adhesion Molecule-1--analysis<br/>Rats<br/>Tissue Plasminogen Activator--genetics<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays